Search Results 1871-1880 of 42284 for oral

  1. White tongue Causes - Mayo Clinic

    Detecting oral cancer: A guide for healthcare professionals. National Institute of Dental and Craniofacial Research. https://www.nidcr.nih.gov/health-info/oral- ...

  2. Mayo Clinic Q and A: Penicillin allergy or not? Why you should find out

    If the oral challenge does not cause a reaction, then the allergy can be removed from your chart. — Nipunie Rajapakse, M.D., Pediatric Infectious Diseases, Mayo ...

  3. Publications - Sarah E. James, M.D., Ph.D. - Mayo Clinic

    ... Oral Androgen Receptor Pathway Inhibitors. Prostate. 2025 Jul; 85 (10):954-965 Epub 2025 May 01. View PubMed; Gevorkyan GS, Chen Q, Tegtmeier RC, Toesca DS ...

  4. Ringworm (scalp) - Diagnosis & treatment - Mayo Clinic

    Learn more on causes, symptoms, treatments of this easily spread, itchy fungal skin infection and how to prevent it.

  5. Erectile dysfunction and diabetes: Take control today - Mayo Clinic

    Oral medicines are pills that you take by mouth. These pills can help ease blood flow to your penis, making it easier to get and keep an erection. Check with ...

  6. Carolyn L. Kinney, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral ExaminerAmerican Board of Physical Medicine and Rehabilitation. 2002 - 2006. SecretaryExecutive Committee, American Board of Physical Medicine and ...

  7. Milk thistle - Mayo Clinic

    Silymarin is believed to have antioxidant properties. Milk thistle is sold as an oral capsule, tablet and liquid extract. People mainly use the supplement to ...

  8. Greg M. Worsowicz, M.D. - Doctors and Medical Staff - Mayo Clinic

    National Oral Board ExaminerAmerican Board of Physical Medicine & Rehabilitation. 2019 - present. Member, Public Policy CommitteeAssociation of Academic ...

  9. Sexual health Women's sexual health - Mayo Clinic

    Barrier methods of birth control such as condoms and dental dams for oral sex help lower the risk of getting most STIs. If you're sexually active, you can ...

  10. TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

    TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell ...